Molecular mechanism study of novel compound heterozygous EOGT mutations leading to Adams-Oliver syndrome type 4

Read full text Summarise with VIRAT
Authors: Yufei He, Xiangyu Liu, Zongrui Shen, Tingting Xu, Fang Yang, Fu Xiong, Yuanling Xiao
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Adams-Oliver Syndrome Type 4 (AOS4) is a rare autosomal recessive disorder primarily characterized by aplasia cutis congenita and cranial defects. Pathogenic variants in several genes, including DOCK6, ARHGAP31, EOGT, RBPJ, DLL4, and NOTCH1 , have been implicated in the etiology of AOS. In this study, we identified two novel compound heterozygous mutations in the EOGT gene (c.961 C>T, p.R321C and c.1115 G>A, p.R372Q) in a patient with AOS4. Both variants were predicted to be deleterious through structural and computational analyses, and these mutations are likely to impair enzymatic function without affecting subcellular localization. Given the established role of EOGT in O-GlcNAcylation and its regulatory relationship with Notch signaling, we further proposed that these mutations may disrupt Notch pathway activity through aberrant modification of Notch receptors, thereby contributing to the defective skin development observed in AOS4. These findings highlight a potential pathogenic mechanism for AOS4 and underscore the critical role of EOGT-mediated glycosylation in human development .

Fields of Study & Subjects

Genetic and rare skin diseases. Congenital limb and hand anomalies Skin and Cellular Biology Research

Publication details

Journal / source
Global Medical Genetics
Volume
13
Issue
2
Pages
100100–100100
Publication date
21 March 2026
Language
EN